ÂÜÀòÂÒÂ×

Gregory T Mrachko, PhD, RAC, currently serves as a Senior Scientist at Sorrento Therapeutics, Inc., specializing in downstream purification since August 2015. Prior experience includes roles as a Senior Research Specialist at The Dow Chemical Company Pfenex Biopharmaceutical Business Unit, where leadership in a DARPA-funded project on vaccine manufacturing was notable, and contributions as a Senior Research Scientist at Enchira Biotechnology Corporation and Energy BioSystems Corporation, focusing on biopharmaceuticals and biodesulfurization technologies, respectively. Educational qualifications include a PhD in Biochemistry and Organic Chemistry from The University of Akron, along with postdoctoral training in genomic and mechanistic enzymology. Additional credentials include a Regulatory Affairs independent study from the University of California, San Diego Extension and a certification in Biofuels Science and Processes from UC San Diego.